SPF30 Sunscreens Delay Melanoma Incidence in Preclinical Model (video) Ohio State University Wexner Medical Center Share Print E-Mail Loading video... Caption Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive Cancer Center Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. This data suggest that the mouse model can be used to identify new, more effective melanoma-preventing agents, according to principal investigator Christin Burd, Ph,D. Burd will present her team's initial findings at the American Association for Cancer Research (AACR) Annual Meeting 2016 on Sunday, April 17, 2016. Credit The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Usage Restrictions used as part of news reporting of initial findings, presented by Ohio State team at AACR 2016 Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.